Advertisement

Other Indications for Deep Brain Stimulation

  • Sarah A. HeschamEmail author
  • Ali Jahanshahi
Chapter
  • 11 Downloads

Abstract

Apart from the commonly accepted indications, deep brain stimulation (DBS) has been applied in patients suffering from addiction, Huntington’s disease, Alzheimer’s disease, anorexia nervosa, minimal conscious state, and schizophrenia in either experimental case studies or initial clinical trials. The rationale for applying DBS in these indications is to modulate a dysfunctional neural structure or circuit, which is considered responsible for the clinical symptoms. In this chapter, we highlight the latest updates in so-called investigational indications of DBS. Although beneficial effects have been reported in most of these indications, one should consider that the mechanisms as well as neural circuits underlying the beneficial effects of DBS remain poorly understood. Understanding these factors will lead to better therapeutic effects of DBS in these and also other indications. Moreover, caution should be applied when performing DBS in neurodegenerative disorders as progressive brain atrophy can lead to unexpected side effects or loss of benefit.

Keywords

Deep brain stimulation Addiction Huntington’s disease Anorexia nervosa Minimally conscious state Alzheimer’s disease Schizophrenia 

References

  1. Bernat JL. Chronic consciousness disorders. Annu Rev Med. 2009;60:381–92.CrossRefPubMedPubMedCentralGoogle Scholar
  2. Bernat JL. The natural history of chronic disorders of consciousness. Neurology. 2010;75:206–7.CrossRefPubMedPubMedCentralGoogle Scholar
  3. Bikovsky L, Hadar R, Soto-Montenegro ML, et al. Deep brain stimulation improves behavior and modulates neural circuits in a rodent model of schizophrenia. Exp Neurol. 2016;283:142–50.CrossRefPubMedPubMedCentralGoogle Scholar
  4. Bird ED. Chemical pathology of Huntington’s disease. Annu Rev Pharmacol Toxicol. 1980;20:533–51.CrossRefPubMedPubMedCentralGoogle Scholar
  5. Bird ED, Spokes EGS, Iversen LL. Dopamine and noradrenaline in post-mortem brain in Huntington’s disease and schizophrenic illness. Acta Psychiatr Scand. 1980;61(S280):63–73.CrossRefPubMedPubMedCentralGoogle Scholar
  6. Bodell LP, Keel PK. Current treatment for anorexia nervosa: efficacy, safety, and adherence. Psychol Res Behav Manag. 2010;3:91–108.CrossRefPubMedPubMedCentralGoogle Scholar
  7. Bonelli RM, Gruber A. Deep brain stimulation in Huntington’s disease. Mov Disord. 2002;17:429–30.CrossRefPubMedPubMedCentralGoogle Scholar
  8. Chudy D, Deletis V, Almahariq F, et al. Deep brain stimulation for the early treatment of the minimally conscious state and vegetative state: experience in 14 patients. J Neurosurg. 2018;128:1189.CrossRefPubMedPubMedCentralGoogle Scholar
  9. Corripio I, Sarró S, McKenna PJ, et al. Clinical improvement in a treatment-resistant patient with schizophrenia treated with deep brain stimulation. Biol Psychiatry. 2016;80:e69–70.CrossRefPubMedPubMedCentralGoogle Scholar
  10. de Jong BM. ‘Complete motor locked-in’ and consequences for the concept of minimally conscious state. J Head Trauma Rehabil. 2013;28:141–3.CrossRefPubMedPubMedCentralGoogle Scholar
  11. Degenhardt L, Charlson F, Ferrari A, et al. The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Psychiatry. 2018;5:987–1012.CrossRefGoogle Scholar
  12. Edwards TC, Zrinzo L, Limousin P, et al. Deep brain stimulation in the treatment of chorea. Mov Disord. 2012;27:357–63.CrossRefPubMedPubMedCentralGoogle Scholar
  13. Favaro A, Ferrara S, Santonastaso S. The spectrum of eating disorders in young women: a prevalence study in a general population sample. Psychosom Med. 2003;65:701–8.CrossRefPubMedPubMedCentralGoogle Scholar
  14. Feigin VL, Abajobir AA, Abate KH, et al. Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurol. 2017;16:877–97.CrossRefGoogle Scholar
  15. Fontaine D, Deudon A, Lemaire JJ, et al. Symptomatic treatment of memory decline in Alzheimer’s disease by deep brain stimulation: a feasibility study. J Alzheimers Dis. 2013;34:315–23.CrossRefPubMedPubMedCentralGoogle Scholar
  16. Gault JM, Davis R, Cascella NG, et al. Approaches to neuromodulation for schizophrenia. J Neurol Neurosurg Psychiatry. 2018;89:777–87.CrossRefPubMedPubMedCentralGoogle Scholar
  17. Gonçalves-Ferreira A, do Couto FS, Rainha Campos A, et al. Deep brain stimulation for refractory cocaine dependence. Biol Psychiatry. 2016;79:e87–9.CrossRefPubMedPubMedCentralGoogle Scholar
  18. Gossop M, Stewart D, Browne N, et al. Factors associated with abstinence, lapse or relapse to heroin use after residential treatment: protective effect of coping responses. Addiction. 2002;97:1259–67.CrossRefPubMedPubMedCentralGoogle Scholar
  19. Graybiel AM. The basal ganglia. Trends Neurosci. 1995;18:60–2.CrossRefPubMedPubMedCentralGoogle Scholar
  20. Guarda AS. Treatment of anorexia nervosa: insights and obstacles. Physiol Behav. 2008;94:113–20.CrossRefPubMedPubMedCentralGoogle Scholar
  21. Hamani C, McAndrews MP, Cohn M, et al. Memory enhancement induced by hypothalamic/fornix deep brain stimulation. Ann Neurol. 2008;63:119–23.CrossRefPubMedPubMedCentralGoogle Scholar
  22. Hebb MO, Garcia R, Gaudet P, et al. Bilateral stimulation of the globus pallidus internus to treat choreathetosis in Huntington’s disease: technical case report. Neurosurgery. 2006;58:E383.CrossRefPubMedPubMedCentralGoogle Scholar
  23. Herrington TM, Cheng JJ, Eskandar EN. Mechanisms of deep brain stimulation. J Neurophysiol. 2016;115:19–38.CrossRefPubMedPubMedCentralGoogle Scholar
  24. Hescham S, Lim L, Jahanshahi A, et al. Deep brain stimulation in dementia-related disorders. Neurosci Biobehav Rev. 2013;37(10 Pt 2):2666–75.CrossRefPubMedPubMedCentralGoogle Scholar
  25. Hoek HW, van Hoeken D. Review of the prevalence and incidence of eating disorders. Int J Eat Disord. 2003;34:383–96.CrossRefPubMedPubMedCentralGoogle Scholar
  26. Jahanshahi AR, Vlamings R, van Roon-Mom WM, et al. Changes in brainstem serotonergic and dopaminergic cell populations in experimental and clinical Huntington’s disease. Neuroscience. 2013;238:71–81.CrossRefPubMedPubMedCentralGoogle Scholar
  27. Joel D. Open interconnected model of basal ganglia-thalamocortical circuitry and its relevance to the clinical syndrome of Huntington’s disease. Mov Disord. 2001;16:407–23.CrossRefPubMedPubMedCentralGoogle Scholar
  28. Klein J, Hadar R, Götz T, et al. Mapping brain regions in which deep brain stimulation affects schizophrenia-like behavior in two rat models of schizophrenia. Brain Stimul. 2013;6:490–9.CrossRefPubMedPubMedCentralGoogle Scholar
  29. Krack P, Hariz MI, Baunez C, et al. Deep brain stimulation: from neurology to psychiatry? Trends Neurosci. 2010;33:474–84.CrossRefPubMedPubMedCentralGoogle Scholar
  30. Kuhn J, Moller M, Treppmann JF, et al. Deep brain stimulation of the nucleus accumbens and its usefulness in severe opioid addiction. Mol Psychiatry. 2014;19:145–6.CrossRefPubMedPubMedCentralGoogle Scholar
  31. Kuhn J, Hardenacke K, Lenartz D, et al. Deep brain stimulation of the nucleus basalis of Meynert in Alzheimer’s dementia. Mol Psychiatry. 2015a;20:353–60.CrossRefPubMedPubMedCentralGoogle Scholar
  32. Kuhn J, Hardenacke K, Shubina E, et al. Deep brain stimulation of the nucleus basalis of Meynert in early stage of Alzheimer’s dementia. Brain Stimul. 2015b;8:838–9.CrossRefPubMedPubMedCentralGoogle Scholar
  33. Laxton AW, Tang-Wai DF, McAndrews MP, et al. A phase I trial of deep brain stimulation of memory circuits in Alzheimer’s disease. Ann Neurol. 2010;68:521–34.CrossRefPubMedPubMedCentralGoogle Scholar
  34. Ligot N, Krystkowiak P, Simonin C, et al. External globus pallidus stimulation modulates brain connectivity in Huntington’s disease. J Cereb Blood Flow Metab. 2011;31:41–6.CrossRefPubMedPubMedCentralGoogle Scholar
  35. Lipsman N, Lam E, Volpini M, et al. Deep brain stimulation of the subcallosal cingulate for treatment-refractory anorexia nervosa: 1 year follow-up of an open-label trial. Lancet Psychiatry. 2017;4:285–94.CrossRefPubMedPubMedCentralGoogle Scholar
  36. Lozano AM, Lipsman N. Probing and regulating dysfunctional circuits using deep brain stimulation. Neuron. 2013;77:406–24.CrossRefPubMedPubMedCentralGoogle Scholar
  37. Lozano AM, Fosdick L, Chakravarty MM, et al. A phase II study of fornix deep brain stimulation in mild Alzheimer’s disease. J Alzheimers Dis. 2016;54:777–87.CrossRefPubMedPubMedCentralGoogle Scholar
  38. Ma J, Leung LS. Deep brain stimulation of the medial septum or nucleus accumbens alleviates psychosis-relevant behavior in ketamine-treated rats. Behav Brain Res. 2014;266:174–82.CrossRefPubMedPubMedCentralGoogle Scholar
  39. Martens HCF, Toader E, Decre MMJ, et al. Spatial steering of deep brain stimulation volumes using a novel lead design. Clin Neurophysiol. 2011;122:558–66.CrossRefPubMedPubMedCentralGoogle Scholar
  40. Martinez-Ramirez D, Morishita T, Zeilman PR, et al. Atrophy and other potential factors affecting long term deep brain stimulation response: a case series. PLoS One. 2014;9:e111561.CrossRefPubMedPubMedCentralGoogle Scholar
  41. Masters CL, Bateman R, Blennow K, et al. Alzheimer’s disease. Nat Rev Dis Primers. 2015;1:15056.CrossRefPubMedPubMedCentralGoogle Scholar
  42. Moro E, Lang AE, Strafella AP, et al. Bilateral globus pallidus stimulation for Huntington’s disease. Ann Neurol. 2004;56:290–4.CrossRefPubMedPubMedCentralGoogle Scholar
  43. Moruzzi G, Magoun HW. Brain stem reticular formation and activation of the EEG. Electroencephalogr Clin Neurophysiol. 1949;1:455–73.CrossRefPubMedPubMedCentralGoogle Scholar
  44. Müller UJ, Voges J, Steiner J, et al. Deep brain stimulation of the nucleus accumbens for the treatment of addiction. Ann N Y Acad Sci. 2013;1282:119–28.CrossRefPubMedPubMedCentralGoogle Scholar
  45. Nestler EJ, Barrot M, DiLeone RJ, et al. Neurobiology of depression. Neuron. 2002;34:13–25.CrossRefPubMedPubMedCentralGoogle Scholar
  46. Oudijn MS, Storosum JG, Nelis E, et al. Is deep brain stimulation a treatment option for anorexia nervosa? BMC Psychiatry. 2013;13:277.CrossRefPubMedPubMedCentralGoogle Scholar
  47. Pelloux Y, Baunez C. Deep brain stimulation for addiction: why the subthalamic nucleus should be favored. Curr Opin Neurobiol. 2013;23:713–20.CrossRefPubMedPubMedCentralGoogle Scholar
  48. Perez SM, Shah A, Asher A, et al. Hippocampal deep brain stimulation reverses physiological and behavioural deficits in a rodent model of schizophrenia. Int J Neuropharmacol. 2013;16:331–1339.Google Scholar
  49. Plewnia C, Schober F, Rilk A, et al. Sustained improvement of obsessive-compulsive disorder by deep brain stimulation in a woman with residual schizophrenia. Int J Neuropsychopharmacol. 2008;11:1181–3.CrossRefPubMedPubMedCentralGoogle Scholar
  50. Price JL, Drevets WC. Neurocircuitry of mood disorders. Neuropsychopharmacology. 2009;35:192.CrossRefGoogle Scholar
  51. Purpura KP, Schiff ND. The thalamic intralaminar nuclei: a role in visual awareness. Neuroscientist. 1997;3:8–15.CrossRefGoogle Scholar
  52. Sankar T, Chakravarty MM, Bescos A, et al. Deep brain stimulation influences brain structure in Alzheimer’s disease. Brain Stimul. 2015;8:645–54.CrossRefPubMedPubMedCentralGoogle Scholar
  53. Schiff ND, Giacino JT, Kalmar K, et al. Behavioural improvements with thalamic stimulation after severe traumatic brain injury. Nature. 2007;448(7153):600–3.CrossRefPubMedPubMedCentralGoogle Scholar
  54. Sieradzan KA, Mann DM. The selective vulnerability of nerve cells in Huntington’s disease. Neuropathol Appl Neurobiol. 2001;27:1–21.CrossRefPubMedPubMedCentralGoogle Scholar
  55. Simeone JC, Ward AJ, Rotella P, et al. An evaluation of variation in published estimates of schizophrenia prevalence from 1990─2013: a systematic literature review. BMC Psychiatry. 2015;15:193.CrossRefPubMedPubMedCentralGoogle Scholar
  56. Smith T, Weston C, Lieberman J. Schizophrenia (maintenance treatment). Am Fam Physician. 2010;82:338–9.PubMedPubMedCentralGoogle Scholar
  57. Smith GS, Laxton AW, Tang-Wai DF, et al. Increased cerebral metabolism after 1 year of deep brain stimulation in Alzheimer disease. Arch Neurol. 2012;69:1141–8.CrossRefPubMedPubMedCentralGoogle Scholar
  58. Spielberger S, Hotter A, Wolf E, et al. Deep brain stimulation in Huntington’s disease: a 4-year follow-up case report. Mov Disord. 2012;27:806–7.CrossRefPubMedPubMedCentralGoogle Scholar
  59. Sussman S, Lisha N, Griffiths M. Prevalence of the addictions: a problem of the majority or the minority? Eval Health Prof. 2011;34:3–56.CrossRefPubMedPubMedCentralGoogle Scholar
  60. Temel Y, Cao C, Vlamings R, et al. Motor and cognitive improvement by deep brain stimulation in a transgenic rat model of Huntington’s disease. Neurosci Lett. 2006;406:138–41.CrossRefPubMedPubMedCentralGoogle Scholar
  61. Tony R. Wang, Shayan Moosa, Robert F. Dallapiazza, et al. Deep brain stimulation for the treatment of drug addiction. Neurosurgical Focus. 2018;45(2):E11.Google Scholar
  62. Torres-Gonzalez F, Ibanez-Casas I, Saldivia S, et al. Unmet needs in the management of schizophrenia. Neuropsychiatr Dis Treat. 2014;10:97–110.CrossRefPubMedPubMedCentralGoogle Scholar
  63. Turnbull IM, McGeer PL, Beattie L, et al. Stimulation of the basal nucleus of Meynert in senile dementia of Alzheimer’s type. A preliminary report. Appl Neurophysiol. 1985;48:216–21.PubMedPubMedCentralGoogle Scholar
  64. Vedam-Mai V, Martinez-Ramirez D, Hilliard JD, et al. Post-mortem findings in Huntington’s deep brain stimulation: a moving target due to atrophy. Tremor Other Hyperkinet Mov. 2016;6:372.Google Scholar
  65. Vigo D, Thornicroft G, Atun R. Estimating the true global burden of mental illness. Lancet Psychiatry. 2016;3:171–8.CrossRefPubMedPubMedCentralGoogle Scholar
  66. Vlamings R, Benazzouz A, Chetrit J, et al. Metabolic and electrophysiological changes in the basal ganglia of transgenic Huntington’s disease rats. Neurobiol Dis. 2012;48:488–94.CrossRefPubMedPubMedCentralGoogle Scholar
  67. Vonsattel JP, Myers RH, Stevens TJ, et al. Neuropathological classification of Huntington’s disease. J Neuropathol Exp Neurol. 1985;44:559–77.CrossRefPubMedPubMedCentralGoogle Scholar
  68. Zeef D, Schaper F, Vlamings R, et al. Deep brain stimulation in Huntington’s disease: the current status. Open Neurosurg J. 2011;4:7–10.CrossRefGoogle Scholar
  69. Zhou H, Xu J, Jiang J. Deep brain stimulation of nucleus accumbens on heroin-seeking behaviors: a case report. Biol Psychiatry. 2011;69:e41–2.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Department of NeurosurgeryMaastricht University Medical CenterMaastrichtThe Netherlands

Personalised recommendations